$TXN — AVOID 📊 | 6 MONTHS THESIS

$TXN — AVOID 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $4.8B | EPS $1.71 vs $1.37 🟢 | Margin 37.5% 💡 Consensus underestimated EPS (1.71 vs. 1.37), but the market has quickly repriced the stock. The quantitative return forecast suggests 1.5% upside vs 7.8% downside, indicating that the remaining expectations gap is minimal and already discounted. 📉 Reward/risk: 0.5:1 🏢 Business Quality: 9/10 📊 Valuation: rich — current P/E of 44.5x on annualized TTM EPS is well above TXN’s historical 20-25x median and above analog peer averages, even after adjusting... 🔮 Catalyst: Next quarterly earnings (Q2 2026) expected around July 2026 💰 Entry: $285.42, stop $70.84, target $179.02 ⚖️ Avoid TXN at $304.36; risk/reward of 0.2:1 unattractive despite strong Q1 beat; high 44x PE limits upside and amplifies downside. 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/TXN0623

🎯 Q1 2026 | Rev $4.8B | EPS $1.71 vs $1.37 🟢 | Margin 37.5%